O, wind, if winter comes … will symptoms be far behind?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

O, wind, if winter comes … will symptoms be far behind?

Published:2021-12-10 Issue:1 Volume:62 Page:2-10
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Patriquin Christopher J.¹²,Pavenski Katerina³⁴

Affiliation:

1. Division of Medical Oncology & Hematology University Health Network, Toronto General Hospital Toronto Canada

2. Department of Medicine University of Toronto Toronto Canada

3. Departments of Medicine & Laboratory Medicine St. Michael's Hospital Toronto Canada

4. Departments of Medicine & Laboratory Medicine University of Toronto Toronto Canada

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16765

Reference69 articles.

1. Cold agglutinin disease revisited: a multinational, observational study of 232 patients

2. Exclusive Occurrence of k Chains in Isolated Cold Haemagglutinins

3. Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma

4. Anti-i: A Cold Antibody Defining the li Relationship in Human Red Cells

5. I blood group system and its relationship to disease;Issitt PD;J Med Lab Technol,1968

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement-directed therapy for cold agglutinin disease: sutimlimab;Expert Review of Hematology;2023-06-02

2. Sutimlimab for the Treatment of Cold Agglutinin Disease;HemaSphere;2023-05

3. The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?;Frontiers in Immunology;2023-04-24

4. Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy?;Transfusion Medicine Reviews;2022-10

5. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?;Immunotherapy;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3